What's breaking now, across thousands of outlets.
BioNTech delivered a compelling piece of evidence Monday supporting the development of its CTLA-4 antibody gotistobart in lung cancer. Previously treated lung cancer patients who received the CTLA-4 antibody lived for 8.5 months longer than ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Researchers at Fox Chase Cancer Center have identified a promising approach to rebuilding tissue after skin cancer surgery that could help some patients avoid more extensive reconstructive procedures.
A new study has revealed why some people with Huntington's disease develop symptoms 10–12 years earlier and experience a more aggressive form of the disease.
Key PointsModerna's recent success in a phase 3 clinical trial for its personalized cancer vaccine was a breakthrough.
Researchers from the University of Liverpool and the University of Zurich have identified a potential safety consideration involving levetiracetam, one of the world's most commonly prescribed…
A Johns Hopkins Medicine study reports evidence that time-restricted eating (TRE)—a form of intermittent fasting that involves eating only during a consistent daily 8–10-hour window—can cause modest…
Stakeholders across the Ahafo Region including traditional authorities, religious leaders, political office holders, media practitioners, policymakers, and healthcare providers have joined hands to declare a firm ‘NO’ to illegal charges and unauthorized out-of-pocket payments within the National Health Insurance Scheme (NHIS).
